Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.

Bison SM, Haeck JC, Bol K, Koelewijn SJ, Groen HC, Melis M, Veenland JF, Bernsen MR, de Jong M.

EJNMMI Res. 2015 Dec;5(1):62. doi: 10.1186/s13550-015-0142-y. Epub 2015 Nov 9.

2.

Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.

Haeck J, Bol K, Bison S, van Tiel S, Koelewijn S, de Jong M, Veenland J, Bernsen M.

Contrast Media Mol Imaging. 2015 Nov-Dec;10(6):413-20. doi: 10.1002/cmmi.1643. Epub 2015 May 21.

PMID:
25995102
3.

Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

Bison SM, Pool SE, Koelewijn SJ, van der Graaf LM, Groen HC, Melis M, de Jong M.

EJNMMI Res. 2014 May 30;4:21. doi: 10.1186/s13550-014-0021-y. eCollection 2014.

4.

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments.

Bison SM, Konijnenberg MW, Melis M, Pool SE, Bernsen MR, Teunissen JJ, Kwekkeboom DJ, de Jong M.

Clin Transl Imaging. 2014;2:55-66. Epub 2014 Mar 5. Review.

5.

mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer.

Pool SE, Bison S, Koelewijn SJ, van der Graaf LM, Melis M, Krenning EP, de Jong M.

Cancer Res. 2013 Jan 1;73(1):12-8. doi: 10.1158/0008-5472.CAN-11-2089. Epub 2012 Nov 13.

6.

Effect of the p38 MAPK inhibitor SB-239063 on Lipopolysaccharide-induced psychomotor retardation and peripheral biomarker alterations in rats.

Bison S, Razzoli M, Arban R, Michielin F, Bertani S, Carboni L.

Eur J Pharmacol. 2011 Jul 1;661(1-3):49-56. doi: 10.1016/j.ejphar.2011.04.020. Epub 2011 Apr 27.

PMID:
21545800
7.

The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.

Large CH, Bison S, Sartori I, Read KD, Gozzi A, Quarta D, Antolini M, Hollands E, Gill CH, Gunthorpe MJ, Idris N, Neill JC, Alvaro GS.

J Pharmacol Exp Ther. 2011 Jul;338(1):100-13. doi: 10.1124/jpet.110.178475. Epub 2011 Apr 12.

PMID:
21487071
8.

Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist.

Leslie CP, Biagetti M, Bison S, Bromidge SM, Di Fabio R, Donati D, Falchi A, Garnier MJ, Jaxa-Chamiec A, Manchee G, Merlo G, Pizzi DA, Stasi LP, Tibasco J, Vong A, Ward SE, Zonzini L.

J Med Chem. 2010 Dec 9;53(23):8228-40. doi: 10.1021/jm100714c. Epub 2010 Nov 5.

PMID:
21053897
9.

Design and synthesis of novel tricyclic benzoxazines as potent 5-HT(1A/B/D) receptor antagonists leading to the discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045).

Bromidge SM, Arban R, Bertani B, Bison S, Borriello M, Cavanni P, Dal Forno G, Di-Fabio R, Donati D, Fontana S, Gianotti M, Gordon LJ, Granci E, Leslie CP, Moccia L, Pasquarello A, Sartori I, Sava A, Watson JM, Worby A, Zonzini L, Zucchelli V.

J Med Chem. 2010 Aug 12;53(15):5827-43. doi: 10.1021/jm100482n.

PMID:
20590088
10.

[Epstein-Barr virus bilateral dacryoadenitis: case report].

Moscovici BK, Romero IL, Vital Filho J, Bison SH.

Arq Bras Oftalmol. 2009 Nov-Dec;72(6):826-8. Portuguese.

11.

Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1-receptor antagonist in the rat.

Kalinichev M, Bradford A, Bison S, Lucas A, Sartori I, Garbati N, Andreetta F, Bate S, Austin NE, Jones DN, Read KD, Alvaro G, Large CH.

Epilepsia. 2010 Aug;51(8):1543-51. doi: 10.1111/j.1528-1167.2009.02482.x. Epub 2010 Jan 7.

12.

Plasmacytoma of the orbit involving lacrimal gland with secondary transformation into multiple myeloma: case report.

Romero IL, Campos FA, Damasceno RW, Vital Filho J, Bison SH.

Arq Bras Oftalmol. 2009 Mar-Apr;72(2):236-8.

13.

[Primary peripheral primitive neuroectodermal tumour of the orbit: case report].

Romero IL, Pereira LS, Campos FA, Vital Filho J, Bison SH.

Arq Bras Oftalmol. 2008 Nov-Dec;71(6):871-3. Portuguese.

14.

Alcohol withdrawal increases neuropeptide Y immunoreactivity in rat brain.

Bison S, Crews F.

Alcohol Clin Exp Res. 2003 Jul;27(7):1173-83.

PMID:
12878925

Supplemental Content

Support Center